Researchers from the departments of dermatology at Wake Forest University Health Sciences and at the University of California, San Francisco, have developed a way to measure the impact that melasma has on health-related quality of life (HRQoL).
HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
Losing a Malpractice Case May Depend on Where You Live
The Cutaneous Connection: Treating Atopic Dermatitis in the Winter
The Role We Play in Addressing Racial Disparity in Dermatology
The Mainstream Patient: February 2
2 Clarke Drive Cranbury, NJ 08512